HPC
ABBV icon

HM Payson & Co’s AbbVie ABBV Stock Holding History

HM Payson & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150M Sell
596,837
-4,875
-0.8% -$1.05M 1.99% 10
2026
Q1 		$131M Buy
601,712
+8,859
+1% +$1.97M 1.89% 12
2025
Q4 		$135M Buy
592,853
+423
+0.1% +$96.4K 1.91% 14
2025
Q3 		$137M Sell
592,430
-3,079
-0.5% -$627K 1.97% 11
2025
Q2 		$111M Sell
595,509
-16,246
-3% -$3.02M 1.75% 15
2025
Q1 		$128M Sell
611,755
-3,948
-0.6% -$768K 2.25% 9
2024
Q4 		$109M Buy
615,703
+37,287
+6% +$6.86M 1.86% 12
2024
Q3 		$114M Buy
578,416
+8,585
+2% +$1.6M 1.96% 8
2024
Q2 		$97.7M Buy
569,831
+262
+0% +$43.4K 1.78% 12
2024
Q1 		$104M Buy
569,569
+986
+0.2% +$170K 1.93% 13
2023
Q4 		$88.1M Buy
568,583
+25,316
+5% +$3.69M 1.82% 15
2023
Q3 		$81M Buy
543,267
+5,972
+1% +$877K 1.9% 13
2023
Q2 		$72.4M Buy
537,295
+12,553
+2% +$1.84M 1.63% 17
2023
Q1 		$83.6M Buy
524,742
+10,405
+2% +$1.59M 2.01% 12
2022
Q4 		$83.1M Buy
514,337
+10,982
+2% +$1.68M 2.07% 12
2022
Q3 		$67.6M Buy
503,355
+11,684
+2% +$1.68M 1.85% 17
2022
Q2 		$75.3M Sell
491,671
-6,436
-1% -$983K 1.93% 13
2022
Q1 		$80.7M Buy
498,107
+18,814
+4% +$2.73M 1.84% 12
2021
Q4 		$64.9M Sell
479,293
-25,416
-5% -$3M 1.41% 24
2021
Q3 		$54.4M Sell
504,709
-14,716
-3% -$1.68M 1.33% 27
2021
Q2 		$58.5M Buy
519,425
+28,810
+6% +$3.24M 1.43% 24
2021
Q1 		$53.1M Buy
490,615
+1,355
+0.3% +$145K 1.41% 22
2020
Q4 		$52.4M Sell
489,260
-19,248
-4% -$1.85M 1.45% 19
2020
Q3 		$44.5M Buy
508,508
+146,864
+41% +$13.8M 1.37% 23
2020
Q2 		$35.5M Buy
361,644
+5,792
+2% +$510K 1.19% 31
2020
Q1 		$27.1M Buy
355,852
+13,623
+4% +$1.16M 1.07% 33
2019
Q4 		$30.3M Sell
342,229
-2,780
-0.8% -$231K 0.97% 37
2019
Q3 		$26.1M Sell
345,009
-15,530
-4% -$1.06M 0.92% 40
2019
Q2 		$26.2M Buy
360,539
+143
+0% +$11.2K 0.94% 39
2019
Q1 		$29M Buy
360,396
+359,616
+46,105% +$29.4M 1.11% 33
2018
Q4 		$72K Sell
780
-320,721
-100% -$28.2M 0.21% 77
2018
Q3 		$30.4M Sell
321,501
-22,681
-7% -$2.15M 1.36% 22
2018
Q2 		$31.9M Buy
344,182
+3,488
+1% +$341K 1.36% 21
2018
Q1 		$32.2M Buy
340,694
+124
+0% +$13.6K 1.33% 25
2017
Q4 		$32.9M Buy
340,570
+64,766
+23% +$6.1M 1.32% 25
2017
Q3 		$24.5M Sell
275,804
-4
-0% -$304 1.05% 34
2017
Q2 		$20M Buy
275,808
+5,068
+2% +$341K 0.9% 39
2017
Q1 		$17.6M Buy
270,740
+2,189
+0.8% +$138K 0.8% 45
2016
Q4 		$16.8M Sell
268,551
-1,370
-0.5% -$83.6K 0.8% 43
2016
Q3 		$17M Sell
269,921
-2,334
-0.9% -$151K 0.83% 43
2016
Q2 		$16.9M Sell
272,255
-10,816
-4% -$659K 0.84% 42
2016
Q1 		$16.2M Buy
283,071
+8,438
+3% +$470K 0.84% 44
2015
Q4 		$16.3M Buy
274,633
+10,983
+4% +$633K 0.84% 37
2015
Q3 		$14.3M Sell
263,650
-27,922
-10% -$1.82M 0.78% 40
2015
Q2 		$19.6M Sell
291,572
-4,310
-1% -$281K 0.97% 32
2015
Q1 		$17.3M Sell
295,882
-15,827
-5% -$956K 0.87% 37
2014
Q4 		$20.4M Sell
311,709
-12,611
-4% -$795K 1.01% 34
2014
Q3 		$18.7M Sell
324,320
-25,097
-7% -$1.39M 0.96% 34
2014
Q2 		$19.7M Sell
349,417
-10,737
-3% -$563K 1.01% 33
2014
Q1 		$18.5M Sell
360,154
-41,321
-10% -$2.09M 0.98% 34
2013
Q4 		$21.2M Sell
401,475
-7,579
-2% -$372K 1.14% 27
2013
Q3 		$18.3M Sell
409,054
-12,051
-3% -$534K 1.06% 29
2013
Q2 		$17.4M Buy
+421,105
New +$18.4M 1.04% 30

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

HM Payson & Co's ABBV Position: Q2 2026 in Review

HM Payson & Co reduced its AbbVie (ABBV) stake by 0.81% in Q2 2026, selling an estimated $1.05M and leaving 596,837 shares worth $150M. The position accounts for 1.99% of the portfolio, ranked #10.

HM Payson & Co first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HM Payson & Co held 596,837 shares of AbbVie worth $150M as of Q2 2026.
  • HM Payson & Co sold 4,875 AbbVie shares in Q2 2026, an estimated $1.05M.
  • AbbVie made up 1.99% of HM Payson & Co's portfolio in Q2 2026, its #10 holding.
  • HM Payson & Co first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.